Neosensory, a company that pioneers devices to send information to the brain non-invasively has announced that it has re...
A more comfortable and reliable blood-sugar monitoring system is being designed at KTH Royal Institute of Technology in ...
Aphria Inc. announced that it had completed its previously announced acquisition of CC Pharma GmbH ("CC Pharma...
Medical device company, REVA Medical has announced the geographic expansion of its commercial operations in seven Europe...
Sandoz Inc., a Novartis division, and Pear Therapeutics has announced the US commercial launch of reSET-O(TM) for patien...
Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced that the firs...
Medidata has announced the addition of executive vice president of Digital and AI Solutions, Sastry Chilukuri to its sen...
Leica Biosystems, the global leader in pathology workflow solutions announced today that the US Patent Office has grante...
Generex Biotechnology Corporation has announced that the company has completed the acquisition of 51% of Regentys Corpor...
MYnd Analytics, a predictive analytics company aimed at improving the delivery of mental health services through the com...
Lupin has announced that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatm...
Stemedica Cell Technologies announced positive results from its Phase I/IIa clinical study for the treatment of ischemic...
Eli Lilly and Loxo Oncology, have announced a definitive agreement for Lilly to acquire Loxo Oncol...
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced Project ALPHA (Analytics fo...
Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activ...
Green Leaf Medical, LLC, a MSO (Multi-State Operator) of medical cannabis facilities in the Northeast United S...
The University of Texas MD Anderson Cancer Centre and 4D pharma has announced a strategic collaboration to evaluate...
Ironwood Pharmaceuticals, Inc. has announced that Michael Shetzline, M.D., Ph.D., will join Ironwood as chief medical of...
Bristol-Myers Squibb Company and Celgene Corporation has announced that they have entered into a definitive merger agree...
Locus Biosciences Inc., a biotechnology company developing precision antibacterial therapies, announced today that it ha...
Generex Biotechnology Corporation has announced that its partially, soon to be fully-owned subsidiary, Olaregen Therapeu...
AstraZeneca has announced that the European Commission (EC) has approved Bevespi Aerosphere (glycopyrronium/formote...
ImaginAb, a clinical stage immuno-oncology imaging company has announced the appointment of Friedhelm Blobel, Ph.D...
Correvio Pharma Corp, a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs h...
Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s ...
The U.S. Food and Drug Administration has approved VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussi...
AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy e...
Doctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to pr...
Alexion Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ULTOMIRIS&trad...
PolarityTE, Inc., a commercial-stage biotechnology company focused on transforming the lives of patients by discovering,...
George A. Williams, M.D, today begins his term as the 123rd president of the American Academy of Ophthalmology (AAO). Dr...
Ocular Therapeutix, a biopharmaceutical company focused on the formulation, development, and commercialization of innova...
Innovus Pharmaceuticals, an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effectiv...
Nuvo Pharmaceuticals Inc. a globally focused, Canadian healthcare company with a portfolio of commercial products today ...
Apellis Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on the development of novel therap...
According to a new research by researchers from the Vascular Physiopathology Laboratory of the IRCCS Neuromed in Pozzill...
Sistema PJSFC (“Sistema”), a publicly traded diversified Russian holding company, announces it has acquired ...
According to a study funded by the National Institute on Aging (NIA), part of the National Institutes of Health, incorpo...
A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant to ta...
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing medicines for addictions and drug overdose, ...
Dr. Reddy’s today announced the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets. It...
DUSA Pharmaceuticals, Inc., ("DUSA"), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd announced that DUSA...
Walgreens Boots Alliance, Inc. and Verily has announced that they will collaborate on multiple projects under a broad ag...
USFDA permitted marketing of the Miris Human Milk Analyzer, a new diagnostic test to aid healthcare professionals in mea...
Merck and Pfizer Inc. has announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study...
Purdue Research Foundation’s Foundry Investment Fund has invested a total of $750,000 in three life scie...
In new research IBM team details a first-of-a-kind "fingernail sensor" prototype to help monitor human health. The weara...
Projected returns on investment in research and development (R&D) for the top 12 biopharmaceutical companies have fa...
Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biophar...
“We can all take steps to help prevent Alzheimer’s disease or slow its course,” says Dr. Mohamme...
Phoenix Life Sciences International Limited, an international adaptive healthcare solutions company has announced that M...
The Board of Directors of Prometic Life Sciences Inc. has announced that it has named Prof. Simon Best as Interim Chief ...
Biotech Start-up company, Relay Therapeutics has announced the successful completion of a $400 million Series C financin...
POLYTECH sold the three millionth implant since its establishment in 1986. The company is the only German manufacturer a...
Merck, a leading science and technology company, has evolved its agreement with Intrexon Corporation for the development...
The preclinical findings published in Cell Reports reveal that activation of a specific transcription factor induces a p...
Gilead Sciences and Scholar Rock Holding Corporation have announced that the companies have entered into a strategi...
Pharma major, Bayer has recently received the European Commission approval for its hemophilia A long-acting injectable m...
Gritstone Oncology, Inc., a clinical-stage biotechnology company developing the next generation of cancer immunotherapie...
Singapore - Smith & Nephew announces that it has agreed to acquire Ceterix Orthopaedics and its Novo...
Amgen and Molecular Partners, a clinical-stage biotech company pioneering the use of DARPin® therapeutics, have...
Erasca, a company dedicated to advancing exceptional scientific approaches to erase cancer, has completed a $42 million ...
Biopharma company Lexicon Pharmaceuticals, Inc. has announced positive topline results from its Phase 1a study of LX9211...
DelSiTech Ltd, a Finnish drug delivery technology and drug development company and InnovareR&D, a leading Mexican ph...
IFM Therapeutics (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel t...
Staten Biotechnology has signed a dyslipidaemia licence option deal worth US$430 million with Novo Nordisk. Unde...
The Global Cannabis Partnership (GCP) is pleased to announce the addition of seven new Members as it continues to grow i...
Orchard Therapeutics, a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patien...
Bristol-Myers Squibb Company has announced that the Committee for Medicinal Products for Human Use (CHMP) of the Europea...
Bristol-Myers Squibb Company and Boston Medical centre, a private, not-for-profit, academic medical centre has announced...
Merck has launched the latest evolution in sterility testing devices, the Steritest™ NEO device, which provides sa...
Eli Lilly and Company has announced an agreement with Hydra Biosciences to acquire all assets related to Hydra's pre-cli...
Eli Lilly and Company has announced that Taltz® (ixekizumab) met the primary and all major secondary endpo...
Molecular manufacturing technology company, Zymergen has announced that it has raised over $400 million in Series C fund...
Growth in healthcare adoption has benefited the API market immensely. There is greater focus on accessibility ...
Psychiatric disorders’ many complexities have stymied scientists looking for clear genetic culprits. But a new gia...
Generex Biotechnology Corporation has announced that the FDA had reviewed the company’s investigational new drug (...
Cambridge Heartwear, a medical provider of low-cost, next-generation wearable heart monitors that uses artificial i...
Amgen and Direct Relief today announced a joint initiative in which Direct Relief will distribute $93 million ...
Health Canada is warning that all products manufactured by Professional Botanicals Inc. may pose serious healt...
Merck, known as MSD outside the United States and Canada, and Instituto Butantan, Sao Paulo, Brazil, a non-profit produc...
A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerabilit...
Most contaminants are invisible to the naked eye. Micro-organisms are fairly small, they pose a severe threat to the saf...
Berkeley Lights, Inc. and Novo Nordisk have announced that Novo Nordisk has purchased the Beacon Optofluidic platform to...
The Menarini Group has recently reached an agreement with Melinta Therapeutics to commercialize meropenem/vaborbactam in...
Batavia Biosciences has announced that the International AIDS Vaccine Initiative (IAVI) and Batavia Bioscience...
Tissue Genesis LLC announced today the release of the Icellator® X, the newest and most advanced system for isolatin...
Roche has announced that it entered into a collaboration with Merck (known as MSD outside the United States and Canada) ...
Roche has announced that Daniel O'Day, CEO Roche Pharmaceuticals and member of the Corporate Executive Committee, will b...
US based company GenEdit has announced the completion of a $8.5 million Series Seed financing round led by new...
Gilead Sciences Inc. a research-based biopharmaceutical company that discovers, develops and commercializes innovative m...
Trianni, Inc. and MacroGenics, Inc. has announced that they have entered into a license agreement for The Trianni Mouse,...
Merck, a leading science and technology company has entered into a licensing agreement with Cyclica Inc. for the use of ...
Seattle-based biotechnology company, Impel NeuroPharma has announced that it has completed a Series D financing totaling...
Diamyd Medical is dedicated to finding a cure for diabetes and other serious inflammatory diseases through pharmaceutica...
Based on its recent analysis of the North American medication adherence market, Frost & Sullivan recognizes Phi...
Vienna-based Biotech Company PhagoMed Biopharma GmbH was yesterday awarded the Austrian Entrepreneurship Award Phön...
Medical Devices company, ResMed has announced that it has entered a definitive agreement to acquire Propeller Health, a ...
Pharma company, Domain Therapeutics has announced a multi-targetdrug discovery collaboration and licensing agreement wit...
argenx, a clinical-stage biotechnology company has announced an exclusive, global collaboration and license agreement fo...
